During the corresponding time, Koru Medical Systems Inc recorded a revenue increase by 18.15 % year on year, sequentially revenue grew by 2.39 %. While revenue at the Koru Medical Systems Inc 's corporate clients
Koru Medical Systems Inc's Comment on Sales, Marketing and Customers
The company primarily serves specialty pharmacies, home infusion providers, and distributors. Its products are mainly sold through a limited number of distributors, with three distributors in the U.S. and six international distributors accounting for approximately 77% of net revenues as of December 31, 2025. One U.S. distributor contributed about 29% of net revenues. Additionally, the company provides education and training materials to clinicians, patients, and patient advocates both in the field and online. Customers mentioned in filings include Command Medical Products, Inc.
In the bustling arena of medical technology, KORU Medical Systems has carved its niche with its innovative focus on patient-centric solutions, particularly in the realm of large-volume subcutaneous infusion systems. At the recent Partnership Opportunities in Drug Delivery (PODD) Conference, the company took a significant stride forward, unveiling data that highlights a pronounced preference among nursing professionals for its flagship product: the KORU FreedomEdge Infusion System. As healthcare systems increasingly consider efficiency and patient comfort in the administration of treatments, KORU s FreedomEdge stands out as an elegant answer to the complexities of oncology infusion in clinic settings. The dat...
KORU Medical Systems, a prominent medical technology company specializing in the development and commercialization of large volume subcutaneous infusion solutions, has recently signed a Phase III clinical supply agreement for a groundbreaking enzyme replacement therapy. This therapy aims to treat a rare endocrinological disease, representing a major stride in the field of medical innovation.The signing of this significant milestone underscores KORU Medical Systems commitment to advancing treatment options for patients with complex medical conditions. By leveraging its expertise in developing patient-centric solutions, KORU Medical aims to deliver innovative therapies that enhance patients quality of life a...
KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent medical technology company specializing in the development, manufacturing, and commercialization of large volume subcutaneous infusion solutions, has recently announced a collaboration aimed at launching a feasibility study. The study will investigate the use of KORU’s Freedom Infusion System, in partnership with a leading global pharmaceutical manufacturer, for the administration of a rare disease therapy that is already commercially available.The collaboration, initiated by KORU Medical, marks a significant step for the company in penetrating the ambulatory infusion market. The Freedom Infusion System, known for its patient-centric approach, is desig...
Koru Medical Systems Inc’s Comment on Sales, Marketing and Customers
The company primarily serves specialty pharmacies, home infusion providers, and distributors. Its products are mainly sold through a limited number of distributors, with three distributors in the U.S. and six international distributors accounting for approximately 77% of net revenues as of December 31, 2025. One U.S. distributor contributed about 29% of net revenues. Additionally, the company provides education and training materials to clinicians, patients, and patient advocates both in the field and online. Customers mentioned in filings include Command Medical Products, Inc.
Sources:
Koru Medical Systems Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Koru Medical Systems Inc’s corporate clients.
For your research, we’ve provided 9 tables on Koru Medical Systems Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
139.77 %